Preclinical sustained analgesia and translational potential of AAV-encoded CaV3.2 peptide aptamers for peripherally targeted pain therapy
Molecular Therapy: Nucleic Acids
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Preclinical sustained analgesia and translational potential of AAV-encoded CaV3.2 peptide aptamers for peripherally targeted pain therapy. // Molecular Therapy: Nucleic Acids. – URL: https://www.sciencedirect.com/science/article/pii/S2162253126003136?dgcid=rss_sd_all
Preclinical sustained analgesia and translational potential of AAV-encoded CaV3.2 peptide aptamers for peripherally targeted pain therapy. Molecular Therapy: Nucleic Acids. https://www.sciencedirect.com/science/article/pii/S2162253126003136?dgcid=rss_sd_all
“Preclinical sustained analgesia and translational potential of AAV-encoded CaV3.2 peptide aptamers for peripherally targeted pain therapy.” Molecular Therapy: Nucleic Acids.
@article{article59109,
title = {Preclinical sustained analgesia and translational potential of AAV-encoded CaV3.2 peptide aptamers for peripherally targeted pain therapy},
journal = {Molecular Therapy: Nucleic Acids},
url = {https://www.sciencedirect.com/science/article/pii/S2162253126003136?dgcid=rss_sd_all}
}